Processa Pharmaceuticals (PCSA) Ending Cash Balance (2012 - 2026)
Processa Pharmaceuticals' Ending Cash Balance was $196,325 in Q2 2026, down 97.2% from $6.94 million a year earlier and down 88.4% from the prior quarter.
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Ending Cash Balance (2012 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at Processa Pharmaceuticals came in at $5.54 million, up 364.8% from FY2024.
- Ending Cash Balance shows a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- In earlier years, Ending Cash Balance was $1.19 million in FY2024 (-74.7%), $4.71 million in FY2023 (-27.6%), $6.5 million in FY2022 (-60.6%) and $16.5 million in FY2021 (+7.0%).
- The Q2 2026 figure marks the lowest quarterly Ending Cash Balance since Q1 2020.
- Compared with a year earlier, Ending Cash Balance was higher in three of the last eight quarters, with growth averaging 21.1%.
- The best year-over-year quarter for Ending Cash Balance over five years was Q4 2025 (growth of 364.8%); the worst was Q2 2026 (a decline of 97.2%).
- Per Business Quant data, PCSA's Ending Cash Balance in the three quarters before Q2 2026 was $1.69 million (Q1 2026), $5.54 million (Q4 2025) and $6.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Processa Pharmaceuticals | 5.22 Mn | -8.52 Mn | - | 196,325.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 196,325.00 |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 5.54 Mn |
| Sep 30, 2025 | 6.31 Mn |
| Jun 30, 2025 | 6.94 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 5.57 Mn |
| Mar 31, 2024 | 8.92 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 6.86 Mn |
| Jun 30, 2023 | 8.68 Mn |
| Mar 31, 2023 | 10.74 Mn |
| Dec 31, 2022 | 6.50 Mn |
| Sep 30, 2022 | 9.05 Mn |
| Jun 30, 2022 | 12.06 Mn |
| Mar 31, 2022 | 14.39 Mn |
| Dec 31, 2021 | 16.50 Mn |
| Sep 30, 2021 | 19.09 Mn |
API Access
Processa Pharmaceuticals Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PCSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "PCSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PCSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();